Literature DB >> 18719380

microRNAs and cancer: an overview.

Pedro P Medina1, Frank J Slack.   

Abstract

MicroRNAs (miRNAs) are a recently discovered class of small RNA molecules that negatively regulate gene expression at the post-transcriptional level. MiRNAs play key roles in development and establishment of cell identity and aberrant metabolism/expression of miRNAs has been linked to human diseases including cancer. Components of the miRNA machinery and miRNAs themselves are involved in many cellular processes that are altered in cancer, such as differentiation, proliferation and apoptosis. Some miRNAs exhibit differential expression levels in cancer and have demonstrated capability to affect cellular transformation, carcinogenesis and metastasis acting either as oncogenes or tumour suppressors. We are only beginning to comprehend the functional repercussions of the gain or loss of particular microRNAs on cancer. Nonetheless, although microRNAs have been discovered in humans a mere eight years ago, a host of promising potential applications in the diagnosis, prognoses and therapy of cancer are emerging at a rapid pace.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18719380     DOI: 10.4161/cc.7.16.6453

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  131 in total

Review 1.  Virus-encoded microRNAs.

Authors:  Adam Grundhoff; Christopher S Sullivan
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

2.  A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck.

Authors:  Zhensheng Liu; Sheng Wei; Hongxia Ma; Mei Zhao; Jeffrey N Myers; Randal S Weber; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2011-09-20       Impact factor: 4.944

3.  Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression.

Authors:  Anna Git; Heidi Dvinge; Mali Salmon-Divon; Michelle Osborne; Claudia Kutter; James Hadfield; Paul Bertone; Carlos Caldas
Journal:  RNA       Date:  2010-04-01       Impact factor: 4.942

4.  Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Authors:  Jennifer Permuth-Wey; Dung-Tsa Chen; William J Fulp; Sean J Yoder; Yonghong Zhang; Christina Georgeades; Kazim Husain; Barbara Ann Centeno; Anthony M Magliocco; Domenico Coppola; Mokenge Malafa
Journal:  Cancer Prev Res (Phila)       Date:  2015-09

Review 5.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

6.  Inhibiting microRNA function in vivo.

Authors:  Pedro P Medina; Frank J Slack
Journal:  Nat Methods       Date:  2009-01       Impact factor: 28.547

7.  MicroRNAs take part in pathophysiology and pathogenesis of Male Pattern Baldness.

Authors:  Hamed R Goodarzi; Ali Abbasi; Mojtaba Saffari; Mohammad B Tabei; Mohammad R Noori Daloii
Journal:  Mol Biol Rep       Date:  2009-10-10       Impact factor: 2.316

Review 8.  Cross-talk between miRNA and Notch signaling pathways in tumor development and progression.

Authors:  Zhiwei Wang; Yiwei Li; Dejuan Kong; Aamir Ahmad; Sanjeev Banerjee; Fazlul H Sarkar
Journal:  Cancer Lett       Date:  2009-12-22       Impact factor: 8.679

Review 9.  Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Kiara A Tulla; Ajay V Maker
Journal:  Langenbecks Arch Surg       Date:  2017-12-07       Impact factor: 3.445

10.  MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice.

Authors:  Sathish K R Padi; Qunshu Zhang; Youcef M Rustum; Carl Morrison; Bin Guo
Journal:  Gastroenterology       Date:  2013-04-22       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.